Today’s new word is “xylazine.” We think we’ve started to learn about fentanyl. Now we must learn about xylazine-fentanyl mix.
Aug. 10, 2022
The use of cannabinoids as anticancer agents
The endocannabinoid system may play a dual role on the regulation of tumor generation and progression
Administration of THC and other cannabinoids exert anticancer actions in animal models of cancer
THC and other cannabinoid receptor-ligands induce cancer cell death and inhibit tumor angiogenesis.
Cannabinoids enhance the anticancer activity of other antineoplastic agents in animal models of cancer.
Cannabinoids are currently being tested as anticancer agents in phase I/II clinical studies.
In conclusion there exist solid scientific evidences supporting that cannabinoids exhibit a remarkable anticancer activity in preclinical models of cancer. Since these agents also show an acceptable safety profile, clinical studies aimed at testing them as single agents or in combinational therapies are urgently needed. Results from these studies are essential to clarify whether cannabinoids (and specifically cannabinoid-based medicines) could be helpful in the fight of cancer.
The above information was provided by Paul Armentano from NORML.
Article By Leonard I. Frieling
“How to choose a lawyer” is the first question asked by a criminal defendant. Whether someone is already charged or just being investigated, the choice of lawyer may be the single most important decision a defendant must make.
I believe, as do many, that experimentation with, use of, or addiction to illicit drugs does not warrant a random death penalty.